Viewing nowRex Tablet 2mg (Glimepiride)
Glimepiride 2mg
Tablet · Prescription medication
Samnam Pharmaceutical Co., Ltd.

MFDS item code 200301134 · Notified 2003.12.16 · Insurance code 653700210
Improvement of glycemic control in type 2 diabetes mellitus
This medicine is used as a treatment to improve blood sugar control in patients with Type 2 diabetes. It can be administered alone in addition to meal and exercise therapy, and when blood sugar control is insufficient, it is taken in combination with insulin or other oral hypoglycemic agents. Particularly, in cases where sulfonylureas or metformin monotherapy is insufficient, it is recommended to be combined with metformin to further enhance blood sugar control. This effectively improves blood sugar management in patients with Type 2 diabetes through various treatment methods.
Adjust the dose individually for each patient. Swallow without chewing with at least 1/2 glass of water. Administer this medicine orally once daily. Take this medicine before breakfast or immediately before the first meal. It is very important not to skip a meal after taking this medicine. 1. Monotherapy 1) Initial dose and dose titration For patients who have not previously received medication, initiate treatment with glimepiride 1 mg once daily. If necessary, increase the dose by 1 mg at intervals of 1 ~ 2 weeks. Generally, there is little additional effect at doses above 4 mg, although some patients have shown better metabolic control when the dose was increased to 6 mg (or 8 mg). If treatment with 4 mg daily is unsuccessful, first consider switching to insulin therapy; otherwise, consider combination therapy with insulin or another oral antidiabetic medicine. 2) Subsequent dose adjustment As diabetes control improves during treatment, the patient's need for this medicine may decrease. Therefore, dose reduction or discontinuation of this medicine may be necessary to avoid hypoglycemia. Dose adjustment should also be considered in the event of weight loss, lifestyle changes, or other factors that may increase the risk of hypoglycemia or hyperglycemia. 3) Switching from another oral hypoglycemic agent to this medicine There is no precise dose equivalence between this medicine and other oral hypoglycemic agents. When switching from another oral hypoglycemic agent to this medicine, it is recommended to follow the method described under Initial dose. That is, initiate treatment with 1 mg daily and adjust the dose at 1 ~ 2-week intervals. The potency and duration of action of the previously administered medicine should be taken into account. 4) Dose monitoring During treatment with this medicine, blood glucose and/or urine glucose levels should be measured regularly, and regular measurement of glycated hemoglobin (HbA1c) is also recommended. In general, hypoglycemia can be promptly controlled by immediately consuming sugar. Hypoglycemia may recur despite successful initial management during treatment with a sulfonylurea. Therefore, patients should be carefully monitored. Severe hypoglycemia requires immediate treatment and follow-up by a physician and may sometimes require hospitalization. 2. Combination therapy 1) Combination therapy with insulin Combination therapy of this medicine with insulin is used in patients with secondary failure, and should be used when fasting blood glucose (FBG) exceeds 150 mg/dL. Administer 8 mg of this medicine once daily with the first meal, and initiate insulin at a low dose, increasing it at approximately weekly intervals according to fasting blood glucose measurements. Once stabilized, capillary blood glucose should be monitored daily whenever possible. Insulin doses should be adjusted periodically while measuring blood glucose and glycated hemoglobin. 2) Combination therapy with metformin If the patient does not respond adequately to the maximum dose of this medicine, addition of metformin may be considered. Published clinical information is available on combination therapy of metformin with other sulfonylureas, such as glibenclamide, glipizide, chlorpropamide, and tolbutamide. In combination therapy with this medicine and metformin, the desired blood glucose level may be achieved by adjusting the dose of each medicine. However, efforts should be made to identify the minimum effective dose of each medicine for glycemic control. There is a risk of hypoglycemia with concomitant administration of this medicine and metformin, and the risk may increase. Appropriate precautions should be taken.
This medicine is not to be used in patients with insulin-dependent diabetes or those in diabetic ketoacidosis or coma. Additionally, it should not be administered to patients who have had allergic reactions to this drug, sulfonylureas, or sulfonamides. It is contraindicated in patients with severely impaired liver or kidney function, and in such cases, switching to insulin therapy is recommended. Women who are pregnant or of childbearing potential, as well as breastfeeding women, should not take this medication. Insulin therapy is also recommended for patients with severe infections, pre and post-operative patients, and those with severe trauma. Patients with gastrointestinal disorders like diarrhea or vomiting are at increased risk of hypoglycemia and should be monitored closely. This medication contains lactose, and it should not be administered to patients with lactose intolerance or related genetic disorders. During the first week, there is a high risk of hypoglycemia, so careful monitoring of blood sugar is essential, particularly for patients with poor nutritional status, irregular eating habits, the elderly, those with compromised kidney or liver function, or those taking other medications. Symptoms of hypoglycemia can include headache, severe hunger, nausea, fatigue, anxiety, confusion, drowsiness, and loss of consciousness, so immediate sugar intake is necessary if these symptoms occur. Visual disturbances, gastrointestinal symptoms, liver function abnormalities, blood abnormalities, and allergic reactions can occur rarely, so if any unusual symptoms appear, consult medical personnel. It is essential to maintain regular meals, exercise, and weight control while taking this medicine, and consistently monitor diabetes status and drug effectiveness. Especially when taking other medications, interactions can occur, so be sure to inform your physician or pharmacist of all medications being taken. In cases of overdose, severe hypoglycemia may occur, requiring immediate emergency treatment and possibly intravenous glucose in a hospital. The safety and efficacy of this medication in children have not been established, and elderly patients may require dose adjustment due to diminished kidney function. Store this medicine out of reach of children and keep it in its original container to prevent degradation.
Hypoglycemia, headache, severe hunger, nausea, vomiting, fatigue, sleep, sleep disturbances, anxiety, aggression, decreased concentration, decreased agility or motivation, depression, confusion, speech abnormalities, aphasia, visual disturbances, tremors, partial paralysis, sensory abnormalities, dizziness, weakness, loss of self-control, temporary mental confusion, brain convulsions, drowsiness, loss of consciousness, coma, shallow breathing, bradycardia, sweating, cool and moist skin, tachycardia, hypertension, palpitations, angina pectoris, deep vein thrombosis, blurred vision, feeling of fullness or pressure in the upper abdomen, abdominal pain, diarrhea, increased liver enzymes, liver dysfunction, bile secretion disorders, jaundice, hepatitis, thrombocytopenia, leukopenia, hemolytic anemia, erythrocytopenia, granulocytopenia, agranulocytosis, pancytopenia, itching, hives, rash, shortness of breath, hypotension, shock, anaphylaxis, angioedema, skin and mucous membrane syndrome, allergic vasculitis, photosensitivity reaction of the skin, decreased serum sodium concentration, taste disturbances, hair loss, weight gain, dizziness, liver dysfunction, abdominal pain, arthralgia, dyspepsia, facial edema, erectile dysfunction, flushing of the face, gastritis
Not everyone experiences these, and they can vary from person to person.
This medicine should be kept in a tightly sealed container to prevent exposure to air or moisture. It is recommended to maintain a storage temperature between 1 degrees and 30 degrees Celsius. By doing so, the effectiveness of the medicine can be safely preserved.
Green oval tablet
30 tablets/bottle, 200 tablets/bottle, 500 tablets/bottle
Even with the same ingredient, strength, dosage form and how it is taken can differ.
Viewing nowGlimepiride 2mg
Tablet · Prescription medication
Samnam Pharmaceutical Co., Ltd.

Glimepiride 1mg
Tablet · Prescription medication
Handok Co., Ltd.

Glimepiride 2mg
Tablet · Prescription medication
Handok Co., Ltd.

Glimepiride 4mg
Tablet · Prescription medication
(Hanmi Pharmaceutical Co., Ltd.)

Glimepiride 2mg
Tablet · Prescription medication
Seoul Pharmaceutical Co., Ltd.

Glimepiride 2mg
Tablet · Prescription medication
Shinpoong Pharmaceutical Co., Ltd.

Glimepiride 2mg
Tablet · Prescription medication
Jongkundang Co., Ltd.

Glimepiride 2mg
Tablet · Prescription medication
IYun Pharmaceuticals Co., Ltd.
Even with the same ingredient, the dose and directions can differ by strength and dosage form. Talk to a doctor or pharmacist before switching from a medication you are already taking.
No questions yet.
For anything that needs medical judgment, consult a doctor or pharmacist.
This drug information is based on data provided by the Korea Ministry of Food and Drug Safety.
Consult a doctor or pharmacist for accurate dosage, administration, and usage instructions.